Merck (MRK) Short term Debt (2009 - 2026)
Merck (MRK) reported Short term Debt of $2.4 billion for Q1 2026, up 79.71% year-over-year from $1.4 billion in Q1 2025, and down 5.6% on a QoQ basis from $2.6 billion in Q4 2025.
Merck (MRK) has 18 years of Short term Debt data on file, last reported at $2.4 billion in Q1 2026.
- Quarterly Short term Debt rose 79.71% year-over-year to $2.4 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.4 billion (up 79.71% YoY) and the FY2025 annual result came in at $2.6 billion, down 2.27% from the prior year.
- Short term Debt declined to $2.4 billion in Q1 2026 per MRK's latest filing, from $2.6 billion in the prior quarter.
- Across five years, Short term Debt topped out at $3.1 billion in Q3 2024 and bottomed at $887.0 million in Q3 2023.
- The 5-year median for Short term Debt is $2.4 billion (2026), against an average of $2.2 billion.
- The widest annual swing landed in 2022, when Short term Debt slumped 83.34%; it then surged 255.02% in 2024.
- Tracing MRK's Short term Debt over 5 years: stood at $1.9 billion in 2022, then fell by 29.5% to $1.4 billion in 2023, then soared by 93.08% to $2.6 billion in 2024, then dropped by 2.27% to $2.6 billion in 2025, then decreased by 5.6% to $2.4 billion in 2026.
- Per Business Quant, the three latest MRK Short term Debt figures stand at $2.4 billion (Q1 2026), $2.6 billion (Q4 2025), and $1.4 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.44 Bn |
| Dec 31, 2025 | 2.59 Bn |
| Sep 30, 2025 | 1.41 Bn |
| Jun 30, 2025 | 1.43 Bn |
| Mar 31, 2025 | 1.36 Bn |
| Dec 31, 2024 | 2.65 Bn |
| Sep 30, 2024 | 3.15 Bn |
| Jun 30, 2024 | 3.07 Bn |
| Mar 31, 2024 | 3.08 Bn |
| Dec 31, 2023 | 1.37 Bn |
| Sep 30, 2023 | 887.00 Mn |
| Jun 30, 2023 | 2.84 Bn |
| Mar 31, 2023 | 2.67 Bn |
| Dec 31, 2022 | 1.95 Bn |
| Sep 30, 2022 | 1.94 Bn |
| Jun 30, 2022 | 2.98 Bn |
| Mar 31, 2022 | 1.21 Bn |
| Dec 31, 2021 | 2.41 Bn |
| Sep 30, 2021 | 3.53 Bn |
| Jun 30, 2021 | 2.49 Bn |
| Mar 31, 2021 | 7.25 Bn |
| Dec 31, 2020 | 6.43 Bn |
| Sep 30, 2020 | 2.42 Bn |
| Jun 30, 2020 | 4.72 Bn |
| Mar 31, 2020 | 6.36 Bn |
| Dec 31, 2019 | 3.61 Bn |
| Sep 30, 2019 | 3.41 Bn |
| Jun 30, 2019 | 3.82 Bn |
| Mar 31, 2019 | 3.18 Bn |
| Dec 31, 2018 | 5.31 Bn |
| Sep 30, 2018 | 3.66 Bn |
| Jun 30, 2018 | 3.38 Bn |
| Mar 31, 2018 | 2.06 Bn |
| Dec 31, 2017 | 3.06 Bn |
| Sep 30, 2017 | 5.16 Bn |
| Jun 30, 2017 | 3.18 Bn |
| Mar 31, 2017 | 5.04 Bn |
| Dec 31, 2016 | 568.00 Mn |
| Sep 30, 2016 | 1.49 Bn |
| Jun 30, 2016 | 644.00 Mn |
| Mar 31, 2016 | 2.11 Bn |
| Dec 31, 2015 | 2.58 Bn |
| Sep 30, 2015 | 2.54 Bn |
| Jun 30, 2015 | 2.48 Bn |
| Mar 31, 2015 | 4.73 Bn |
| Dec 31, 2014 | 2.70 Bn |
| Sep 30, 2014 | 9.28 Bn |
| Jun 30, 2014 | 4.48 Bn |
| Mar 31, 2014 | 8.56 Bn |
| Dec 31, 2013 | 4.52 Bn |
| Sep 30, 2013 | 3.98 Bn |
| Jun 30, 2013 | 5.58 Bn |
| Dec 31, 2012 | 4.32 Bn |
| Jun 30, 2012 | 3.92 Bn |
| Mar 31, 2012 | 2.93 Bn |
| Dec 31, 2011 | 1.99 Bn |
| Sep 30, 2011 | 2.46 Bn |
| Jun 30, 2011 | 2.52 Bn |
| Mar 31, 2011 | 2.20 Bn |
| Dec 31, 2010 | 2.40 Bn |
| Sep 30, 2010 | 4.12 Bn |
| Jun 30, 2010 | 4.15 Bn |
| Mar 31, 2010 | 3.82 Bn |
| Dec 31, 2009 | 1.38 Bn |
| Sep 30, 2009 | 185.00 Mn |
| Jun 30, 2009 | 261.00 Mn |